past
decad
previous
unknown
coronavirus
cov
sever
acut
respiratori
syndrom
cov
sarscov
middl
east
respiratori
syndrom
cov
merscov
focus
medic
scientif
media
attent
lethal
natur
epidem
potenti
novemb
first
case
sar
occur
foshan
china
june
first
case
mer
die
hospit
jeddah
saudi
arabia
zoonot
diseas
remain
world
health
organ
list
blueprint
prioriti
diseas
remain
global
threat
global
public
health
secur
review
focus
histor
epidemiolog
clinic
featur
sar
cov
human
cov
known
caus
human
diseas
manifest
mild
symptom
like
common
cold
adult
sever
diseas
infant
elderli
immunosuppress
novemb
unusu
case
atyp
pneumonia
unknown
caus
occur
foshan
citi
guangdong
provinc
china
mani
health
care
worker
becam
infect
infect
brought
hong
kong
februari
physician
look
similar
case
atyp
pneumonia
mainland
china
lead
subsequ
outbreak
sever
pneumonia
hong
kong
label
sever
acut
respiratori
syndrom
march
sever
month
elaps
sever
hundr
case
sar
observ
sarscov
identifi
novel
b
cov
sarscov
lineag
b
confirm
caus
atyp
pneumonia
case
march
sarscov
epidem
spread
countri
region
evid
global
public
health
medic
scientif
commun
adequ
prepar
emerg
sar
chain
humantohuman
transmiss
occur
toronto
canada
hong
kong
special
administr
region
china
chines
taipei
singapor
hanoi
viet
nam
histori
sar
epidem
short
declar
end
sar
epidem
juli
total
sar
case
includ
death
report
countri
region
fig
show
geograph
map
distribut
sar
case
epidem
sar
caus
major
disrupt
intern
air
travel
major
impact
health
servic
busi
affect
countri
sinc
juli
occas
sar
reappear
attribut
breach
laboratori
biosafeti
singapor
taipei
beij
case
associ
chain
transmiss
hospit
spread
fourth
incid
guangdong
provinc
china
result
sporad
communityacquir
case
period
decemb
januari
three
case
expos
anim
environment
sourc
commun
transmiss
coronavirus
order
nidoviral
famili
coronavirida
subfamili
coronavirina
group
envelop
positivesens
singlestrand
highli
divers
rna
virus
divid
genera
b
g
cov
may
caus
diseas
vari
sever
differ
system
human
anim
speci
march
novel
group
b
cov
confirm
caus
agent
respons
sarscov
infect
genom
sequenc
sarscov
bear
close
relationship
previous
identifi
cov
sarscov
genom
consist
methyl
cap
polyadenyl
tail
partial
overlap
termin
open
read
frame
within
twothird
cov
genom
encod
larg
replicas
polyprotein
polyprotein
cleav
serin
proteas
papainlik
cystein
proteas
produc
nonstructur
protein
rna
polymeras
helicas
import
enzym
involv
transcript
replic
cov
onethird
cov
genom
encod
structur
protein
spike
envelop
e
membran
nucleocapsid
n
import
viruscel
receptor
bind
assembl
virion
accessori
protein
nonstructur
protein
may
immunomodulatori
effect
data
retrospect
serolog
studi
done
guangzhou
southern
china
suggest
sarscov
might
transmit
anim
speci
human
wet
market
high
seropreval
found
among
asymptomat
wild
anim
salesmen
highli
similar
variant
sarscov
detect
palm
civet
anim
market
locat
shenzhen
mask
palm
civet
assum
account
transmiss
sarscov
human
wild
anim
handler
found
posit
serolog
sarscov
infect
compar
control
guangdong
provinc
addit
sarscov
case
aros
earli
stage
outbreak
associ
histori
exposur
anim
market
assumpt
enhanc
epidemiolog
linkag
patient
indirect
direct
contact
palm
civet
sporad
outbreak
sarscov
infect
occur
guangzhou
decemb
januari
subsequ
howev
chines
horsesho
bat
found
carri
sarslik
cov
high
degre
nucleotid
sequenc
similar
human
civet
cat
isol
suggest
bat
could
well
natur
sourc
earli
ancestor
sarscov
remain
uncertain
whether
intermedi
mammalian
host
involv
human
transmiss
sever
acut
respiratori
syndrom
pathogenesi
sar
complex
fulli
defin
multipl
factor
govern
widerang
clinic
manifest
mild
sever
diseas
apart
respiratori
tract
sarscov
infect
sever
organ
cell
type
cours
diseas
includ
intestin
mucos
cell
renal
tubular
epitheli
cell
neuron
cell
lymphoid
reticuloendotheli
system
entri
host
cell
patholog
sarscov
invad
human
respiratori
tract
entri
site
infect
occur
step
receptor
bind
conform
chang
glycoprotein
cathepsin
l
proteolysi
within
endosom
entri
sarscov
mediat
angiotensinconvert
enzym
metallopeptidas
express
mani
human
organ
tissu
host
function
receptor
present
abundantli
epithelia
human
lung
small
intestin
presenc
may
sole
requir
sarscov
tropism
one
exampl
despit
abund
express
vascular
endotheli
cell
intestin
smooth
muscl
cell
sarscov
detect
cell
wherea
found
colon
enterocyt
hepatocyt
without
express
histolog
sever
autopsi
patient
sar
show
predomin
patholog
find
diffus
alveolar
damag
dad
lung
histopatholog
patient
sar
includ
dad
loss
cilia
squamou
metaplasia
denud
bronchial
epithelia
giantcel
infiltr
mark
increas
macrophag
alveoli
interstitium
may
contribut
develop
dad
sarscov
infect
glycoprotein
sarscov
could
reduc
express
mous
model
inject
sarscov
glycoprotein
worsen
acut
lung
injuri
ali
vivo
could
reduc
block
reninangiotensin
pathway
addit
overexpress
sarscov
protein
express
lung
intestin
tissu
patient
sar
could
induc
apoptosi
vitro
splenic
atrophi
white
pulp
hemophagocytosi
hyalin
membran
secondari
bacteri
pneumonia
observ
lesion
resembl
cryptogen
organ
pneumonia
cop
subpleur
region
also
seen
extens
express
sarscov
antigen
type
pneumocyt
cynomolgu
macaqu
experiment
infect
sarscov
note
day
suggest
type
pneumocyt
might
earli
primari
target
sarscov
infect
diarrhea
present
sar
case
specimen
obtain
colonoscopi
postmortem
examin
activ
viral
replic
note
within
small
larg
intestin
minim
architectur
disrupt
sarscov
infect
confirm
viral
cultur
specimen
sarscov
rna
detect
stool
specimen
almost
week
ill
onset
presenc
diarrhea
mortal
associ
higher
nasopharyng
sarscov
viral
load
day
ill
onset
innat
acquir
immun
respons
enabl
contain
viru
mild
diseas
cytokin
dysregul
viral
cytopath
effect
downregul
lung
ace
abnorm
immun
respons
autoimmun
mechan
may
lead
sever
diseas
death
diseas
progress
sar
may
relat
activ
thelper
cellmedi
immun
hyperinn
inflammatori
respons
mark
increas
inflammatori
cytokin
interferong
ifng
note
week
ill
onset
studi
adult
sarscov
infect
togeth
mark
increas
chemokin
chemokin
ifnginduc
neutrophil
chemokin
monocyt
chemoattract
mice
infect
sarscov
cell
play
import
role
sarscov
clearanc
wherea
reduc
tcell
respons
contribut
sever
diseas
anoth
studi
mice
infect
sarscov
robust
viru
replic
accompani
delay
type
ifn
ifni
respons
observ
orchestr
inflammatori
respons
lung
immunopatholog
reduc
surviv
earli
administr
ifni
amelior
immunopatholog
delay
ifni
signal
thought
promot
accumul
pathogen
inflammatori
monocytemacrophag
lead
elev
lung
cytokinechemokin
level
vascular
leakag
impair
virusspecif
tcell
respons
wherea
genet
ablat
ifnab
receptor
inflammatori
monocytemacrophag
deplet
protect
mice
fatal
infect
without
affect
viral
load
addit
tolllik
receptor
tlr
signal
tir
domaincontain
adapterinduc
infb
trif
adaptor
protein
might
play
role
protect
mice
lethal
sarscov
diseas
base
studi
innat
respons
mice
trifrel
adapt
molecul
tram
mice
prone
sarscov
infect
wildtyp
mice
although
transient
weight
loss
without
mortal
contrast
mice
defici
adaptor
trif
highli
suscept
sarscov
infect
mark
weight
loss
patholog
condit
lung
higher
viral
titer
impair
lung
function
mortal
trif
mice
infect
sarscov
distinct
chang
inflamm
occur
includ
excess
infiltr
neutrophil
inflammatori
cell
correl
increas
patholog
condit
known
caus
acut
respiratori
distress
syndrom
ard
aberr
proinflammatori
cytokin
chemokin
infstimul
gene
signal
program
observ
follow
infect
trif
mice
resembl
seen
human
patient
poor
clinic
outcom
follow
sarscov
infect
find
suggest
import
tlr
adaptor
signal
gener
balanc
protect
innat
immun
respons
highli
pathogen
cov
infect
addit
sarscov
protein
may
function
cytosol
pathogenassoci
molecular
pattern
stimul
ifnb
product
activ
tlrrelat
signal
cascad
casecontrol
studi
conduct
chines
patient
sarscov
infect
healthi
control
shown
genet
variant
receptor
predispos
sarscov
infect
anoth
casecontrol
studi
shown
mannosebind
lectin
mbl
key
molecul
innat
immun
function
anteantibodi
specif
antibodi
respons
contribut
firstlin
host
defens
sarscov
mbl
defici
predispos
factor
sarscov
infect
macaqu
infect
sarscov
evid
antispik
immunoglobulin
g
igg
caus
sever
ali
alter
macrophag
inflammationresolv
respons
infect
lung
acut
infect
macaqu
function
polar
alveolar
macrophag
demonstr
woundheal
proinflammatori
characterist
simultan
howev
presenc
sigg
clearanc
viru
abort
woundheal
respons
promot
product
recruit
proinflammatori
monocytesmacrophag
interestingli
sera
patient
succumb
sarscov
infect
enhanc
sarscovinduc
product
human
monocytederiv
woundheal
macrophag
wherea
blockad
fcg
receptor
reduc
effect
find
reveal
mechan
respons
virusmedi
ali
defin
patholog
consequ
viralspecif
antibodi
respons
addit
provid
insight
potenti
target
treatment
sarscov
chest
hospit
guangzhou
citi
retrospect
studi
patient
hospit
atyp
pneumonia
januari
februari
show
posit
cultur
sarscov
nasopharyng
aspir
patient
posit
serolog
sarscov
patient
genet
sequenc
viru
isol
patient
guangdong
found
subsequ
prototyp
sarscov
found
affect
area
around
world
index
case
major
sarscov
outbreak
hong
kong
male
renal
physician
travel
guangdong
provinc
februari
hong
kong
sarscov
transmit
least
patron
hotel
stay
floor
renal
physician
subsequ
die
sever
pneumonia
day
later
hospit
near
hotel
within
week
catalyz
speed
intern
air
travel
infect
hotel
patron
spread
sarscov
countriesregion
main
mode
spread
sarscov
seem
close
contact
infect
person
transmit
via
respiratori
droplet
contact
fomit
superspread
event
princ
wale
hospit
pwh
hong
kong
highlight
nosocomi
transmiss
potenti
sarscov
infect
man
visitor
stay
floor
hotel
admit
gener
medic
ward
hospit
fever
pneumonia
march
led
subject
includ
previous
healthi
health
care
worker
contract
diseas
within
period
exposur
overcrowd
medic
ward
environ
inadequ
air
chang
hospit
ward
administr
nebul
salbutamol
index
patient
via
jet
nebul
mucociliari
clearanc
effect
seem
contribut
superspread
event
sarscov
detect
respiratori
tract
secret
urin
fece
tear
patient
sarscov
infect
comput
fluid
dynam
analysi
conjunct
investig
temporalspati
pattern
spread
sarscov
infect
among
inpati
affect
medic
ward
implic
airborn
transmiss
multiag
model
analysi
scenario
use
examin
contribut
differ
mode
transmiss
ward
outbreak
found
sarscov
like
spread
via
combin
longrang
airborn
fomit
rout
fomit
play
nonneglig
role
transmiss
toronto
sarscov
found
polymeras
chain
reaction
pcr
test
environment
air
sampl
taken
hospit
room
occupi
patient
sarscov
infect
well
convent
surfac
swab
taken
bed
tabl
patient
televis
remot
control
medic
refriger
door
nurs
station
possibl
airborn
transmiss
indic
data
emphas
imper
take
appropri
respiratori
protect
addit
strict
surfac
hygien
practic
box
show
key
timelin
spread
sarscov
infect
china
singapor
taiwan
vietnam
canada
via
opportunist
airborn
transmiss
seem
respons
major
commun
outbreak
sarscov
infect
involv
peopl
hong
kong
privat
residenti
complex
amoy
garden
toronto
initi
remov
list
area
recent
local
sar
transmiss
provincewid
scale
back
sar
control
measur
fever
surveil
monitor
respiratori
symptom
exist
inpati
visitor
howev
month
sarscov
outbreak
thought
end
anoth
surg
case
aros
toronto
rehabilit
hospit
involv
health
care
worker
visitor
patient
expos
hospit
patient
undiagnos
sarscov
infect
toronto
final
free
local
transmiss
sarscov
creation
infecti
aerosol
move
upward
warm
airshaft
apart
build
may
dri
ubend
drainag
bathroom
floor
backflow
contamin
sewag
sar
patient
renal
failur
diarrhea
combin
neg
pressur
gener
toilet
exhaust
fan
suggest
via
comput
fluid
dynam
model
longrang
airborn
transmiss
nearbi
build
possibl
caus
wind
flow
dispers
main
mode
sarscov
transmiss
via
respiratori
droplet
although
potenti
transmiss
opportunist
airborn
rout
via
aerosolgener
procedur
health
care
facil
environment
factor
case
amoy
garden
known
transmiss
rout
lead
spread
sarscov
includ
fecoor
presenc
viru
stool
diarrhea
symptom
fomit
surfac
viru
found
surfac
hospit
treat
patient
sarscov
sarscov
spread
worldwid
due
singl
viru
strain
wide
rang
clinic
manifest
seen
patient
sar
mild
moder
sever
rapidli
progress
fulmin
diseas
estim
mean
incub
period
sarscov
infect
day
ci
day
ill
onset
occur
within
day
mean
time
symptom
onset
hospit
day
shorter
toward
later
phase
epidem
mean
time
symptom
onset
need
invas
mechan
ventil
imv
death
day
respect
major
clinic
featur
sar
fever
rigor
chill
myalgia
dri
cough
malais
dyspnea
headach
sore
throat
sputum
product
rhinorrhea
nausea
vomit
dizzi
less
common
tabl
wateri
diarrhea
present
patient
sar
tend
occur
week
ill
onset
sarscov
detect
serum
cerebrospin
fluid
patient
complic
statu
epilepticu
elderli
patient
sarscov
infect
might
present
poor
appetit
decreas
gener
wellb
fractur
result
fall
confus
elderli
subject
might
abl
mount
febril
respons
contrast
sarscov
infect
children
age
less
year
gener
mild
wherea
infect
teenag
resembl
adult
mortal
among
young
children
teenag
sarscov
infect
acquir
pregnanc
carri
case
fatal
rate
associ
high
incid
spontan
miscarriag
preterm
deliveri
intrauterin
growth
retard
without
perinat
sarscov
infect
among
newborn
infant
asymptomat
sarscov
infect
uncommon
metaanalysi
shown
overal
seropreval
rate
ci
gener
popul
health
care
worker
ci
comparison
healthi
blood
donor
other
gener
commun
patient
without
sarscov
infect
recruit
health
care
set
ci
clinic
cours
patient
sarscov
infect
seem
manifest
differ
stage
first
week
ill
sarscov
infect
mani
patient
present
fever
dri
cough
myalgia
malais
might
improv
despit
presenc
lung
consolid
rise
viral
load
serial
sampl
second
week
mani
patient
experienc
recurr
fever
worsen
consolid
respiratori
failur
patient
progress
ard
requir
imv
peak
viral
load
day
ill
correspond
tempor
peak
extent
consolid
radiograph
maxim
risk
nosocomi
transmiss
particularli
health
care
worker
detect
rate
sarscov
infect
use
revers
transcriptas
pcr
rtpcr
nasopharyng
specimen
urin
stool
blood
shown
tabl
import
collect
combin
upper
respiratori
nasal
pharyng
nasopharyng
lower
respiratori
higher
yield
higher
viral
level
eg
sputum
tracheal
aspir
bronchoalveolar
lavag
blood
fecal
specimen
maxim
chanc
detect
singl
neg
test
upper
respiratori
specimen
rule
diagnosi
viral
kinet
demonstr
invert
vshape
curv
peak
day
ill
progress
decreas
rate
viral
shed
nasopharynx
stool
urin
might
persist
day
clinic
progress
second
week
thought
relat
immunemedi
lung
injuri
specimen
viral
cultur
requir
process
biosafeti
level
facil
result
take
long
assist
acut
clinic
manag
serolog
diagnosi
larg
retrospect
use
epidemiolog
surveil
purpos
robust
igg
respons
observ
sever
sarscov
infect
reflect
higher
igg
level
patient
requir
supplement
oxygen
intens
care
unit
icu
admiss
neg
predischarg
fecal
rtpcr
result
lymphopenia
present
studi
beij
shown
year
sarscov
infect
specif
igg
ab
sarscov
eventu
disappear
peripher
memori
bcell
respons
becam
undetect
recov
patient
sar
specif
tcell
anamnest
respons
could
maintain
least
year
absolut
lymphopenia
lymphocyt
count
l
observ
case
sarscov
infect
wherea
low
lymphocyt
count
hospit
associ
advers
clinic
outcom
liver
dysfunct
abnorm
alanin
transaminas
note
patient
present
increas
receiv
system
corticosteroid
ribavirin
treatment
sarscov
infect
radiograph
featur
sarscov
infect
basic
nonspecif
quarter
patient
might
unremark
chest
radiograph
initi
sever
acut
respiratori
syndrom
nonspecif
chang
rang
normal
peribronchi
thicken
illdefin
airspac
shadow
fig
highresolut
comput
tomographi
hrct
thorax
could
detect
small
parenchym
lesion
earli
common
hrct
find
includ
interlobular
septal
intralobular
interstiti
thicken
consolid
groundglass
opacif
predominantli
involv
peripher
lung
field
lower
lobe
featur
close
resembl
found
cop
fig
icu
case
seri
critic
ill
patient
patient
develop
pneumomediastinum
spontan
patient
develop
evid
ard
period
week
despit
use
lung
protect
imv
low
tidal
volum
barotrauma
occur
critic
ill
case
sarscov
infect
possibl
owe
decreas
lung
complianc
prognost
factor
associ
poor
outcom
icu
admiss
death
sarscov
infect
summar
box
infant
preterm
fullterm
born
mother
infect
sarscov
infect
neither
shed
sarscov
clinic
infect
postnat
period
clinic
cours
sarscov
infect
elderli
patient
particularli
comorbid
typic
fulmin
often
fatal
ribavirin
nucleosid
analog
wide
prescrib
treatment
sarscov
infect
nevertheless
ribavirin
monotherapi
minim
activ
sarscov
concentr
could
achiev
clinic
set
led
signific
hemolysi
mani
patient
antivir
therapi
efficaci
antivir
agent
includ
ribavirin
proteas
inhibitor
inf
use
treat
patient
sarscov
infect
summar
tabl
lack
prospect
random
placebocontrol
clinic
trial
data
none
therapi
proven
benefit
good
support
care
remain
mainstay
treatment
sarscov
infect
system
corticosteroid
form
intraven
puls
methylprednisolon
mp
given
patient
sarscov
infect
sever
reason
firstli
assumpt
clinic
progress
pneumonia
respiratori
failur
associ
peak
sarscov
viral
load
might
mediat
host
inflammatori
respons
also
mani
patient
hrct
histolog
featur
cop
steroidrespons
condit
system
corticosteroid
significantli
reduc
concentr
day
treatment
adult
sarscov
infect
addit
patient
fatal
sarscov
infect
evid
hemophagocytosi
lung
attribut
cytokin
dysregul
intervent
system
corticosteroid
thu
given
modul
immun
respons
although
clinic
improv
patient
resolut
fever
lung
consolid
follow
treatment
intraven
puls
mp
retrospect
cohort
analysi
hong
kong
show
use
puls
mp
actual
associ
increas
risk
mortal
adjust
odd
ratio
ci
addit
prolong
use
system
corticosteroid
therapi
box
poor
prognost
factor
associ
intens
care
unit
admiss
andor
death
patient
sever
acut
respiratori
syndrom
coronaviru
infect
advanc
age
viral
load
high
sarscov
viral
load
nasopharyng
secret
high
plasma
sarscov
concentr
comorbid
chronic
hepat
b
diabet
mellitu
comorbid
condit
laboratori
marker
high
peak
lactat
dehydrogenas
ldh
high
initi
ldh
level
high
neutrophil
count
present
low
count
present
data
ref
sever
acut
respiratori
syndrom
could
increas
risk
nosocomi
infect
dissemin
fungal
diseas
metabol
derang
psychosi
osteonecrosi
random
control
trial
shown
plasma
sarscov
rna
concentr
second
third
week
ill
higher
patient
given
initi
hydrocortison
n
given
normal
salin
control
n
earli
clinic
cours
ill
data
suggest
system
corticosteroid
given
earli
cours
sarscov
infect
might
prolong
viremia
systemat
review
conclud
system
corticosteroid
treatment
associ
definit
benefit
potenti
harm
convalesc
plasmapass
immunotherapi
convalesc
plasma
donat
mostli
health
care
worker
fulli
recov
sarscov
infect
seem
clinic
use
treat
patient
progress
sarscov
infect
studi
compar
patient
sarscov
infect
receiv
convalesc
plasma
patient
receiv
therapi
higher
surviv
rate
vs
higher
discharg
rate
vs
compar
control
exploratori
post
hoc
metaanalysi
studi
sarscov
infect
sever
influenza
show
tabl
agent
appli
treatment
human
sever
acut
respiratori
syndrom
coronaviru
infect
ribavirin
given
g
three
time
day
oral
wk
result
drop
hemoglobin
gdl
baselin
patient
evid
hemolysi
document
base
higher
dosag
ribavirin
treat
hemorrhag
fever
viru
patient
sarscov
infect
toronto
develop
toxic
includ
elev
transaminas
bradycardia
proteas
inhibitor
two
retrospect
match
cohort
studi
compar
clinic
outcom
patient
receiv
proteas
inhibitor
lopinavir
mgritonavir
mg
addit
ribavirin
either
initi
therapi
within
onset
symptom
rescu
therapi
puls
methylprednisolon
treatment
worsen
respiratori
symptom
compar
histor
control
receiv
ribavirin
alon
initi
antivir
therapi
addit
lopinavirritonavir
initi
therapi
associ
reduc
overal
death
rate
intub
rate
comparison
match
cohort
receiv
standard
treatment
respect
also
evid
reduct
viral
load
benefici
effect
includ
reduct
methylprednisolon
use
less
nosocomi
infect
howev
subgroup
receiv
lopinavirritonavir
rescu
therapi
fare
better
match
cohort
receiv
higher
mean
dose
methylprednisolon
improv
clinic
outcom
patient
receiv
lopinavirritonavir
part
initi
therapi
support
observ
peak
mgml
trough
mgml
serum
concentr
lopinavir
could
inhibit
viru
uncontrol
studi
toronto
given
within
ill
result
improv
oxygen
satur
rapid
resolut
radiograph
lung
opac
lower
rate
intub
vs
death
vs
howev
sampl
size
small
n
vs
confound
concomit
use
system
corticosteroid
data
ref
signific
reduct
pool
odd
mortal
follow
convalesc
plasma
versu
placebo
treatment
ci
earli
administr
convalesc
plasma
seem
effect
among
patient
sarscov
infect
given
convalesc
plasma
pwh
discharg
rate
day
patient
n
treat
within
day
ill
onset
versu
n
treat
beyond
day
absenc
wellproven
effect
antivir
therapi
convalesc
plasma
human
monoclon
antibodi
worth
studi
treatment
sarscov
return
protein
sarscov
play
import
role
mediat
viral
infect
via
receptor
bind
membran
fusion
virion
host
cell
major
epitop
adenoviralbas
vaccin
could
induc
strong
sarscovspecif
immun
respons
rhesu
macaqu
hold
promis
develop
protect
vaccin
sarscov
investig
report
gene
dna
vaccin
could
induc
product
specif
igg
antibodi
sarscov
effici
mice
seroconvers
ratio
dose
immun
wherea
viral
replic
reduc
order
magnitud
lung
mice
vaccin
plasmid
dna
express
vector
protect
mediat
humor
immun
mechan
recombin
protein
exhibit
antigen
receptorbind
abil
wherea
synthet
peptid
elicit
specif
antibodi
sarscov
protein
might
provid
anoth
approach
develop
sar
vaccin
prevent
transmiss
crucial
manag
highli
infecti
diseas
primari
mode
transmiss
sarscov
infect
direct
contact
exposur
infecti
respiratori
droplet
fomit
therefor
necessari
maintain
good
person
environment
hygien
implement
stringent
contact
droplet
precaut
among
health
care
worker
prevent
commun
transmiss
contact
trace
quarantineisol
close
contact
public
educ
import
measur
decemb
januari
new
case
sarscov
infect
emerg
guangdong
link
establish
human
small
wild
anim
guangdong
govern
depart
public
health
took
public
health
measur
implement
strict
control
wildlif
market
includ
ban
rear
transport
slaughter
sale
food
process
small
wild
mammal
civet
cat
nosocomi
transmiss
hallmark
sarscov
infect
patient
sar
global
health
care
worker
plausibl
reason
viral
load
reach
highest
level
day
diseas
onset
patient
symptomat
dyspneic
close
observationtreat
patient
becam
necessari
health
care
worker
differ
medic
ward
design
patient
triag
undifferenti
fever
confirm
sar
case
patient
sar
rule
event
late
detect
nosocomi
outbreak
hospit
closur
requir
contain
onward
diseas
transmiss
howev
outbreak
detect
earli
sever
acut
respiratori
syndrom
limit
patient
may
manag
isol
infect
patient
place
altern
reloc
affect
patient
design
locat
earli
case
detect
follow
isol
ideal
perform
neg
pressur
isol
room
avail
implement
droplet
precaut
contact
precaut
seem
adequ
reduc
risk
infect
gener
exposur
patient
mild
sarscov
infect
airborn
precaut
hand
hygien
gown
glove
mask
eye
protect
implement
aerosolgener
procedur
undertaken
sar
epidem
demonstr
novel
highli
pathogen
virus
cross
animalhuman
barrier
remain
major
threat
global
health
secur
sar
pose
major
challeng
global
public
health
servic
sudden
appear
rapid
spread
disappear
knowledg
lesson
learnt
sarscov
epidemiolog
mode
transmiss
clinic
cours
complic
clinic
manag
predictor
poor
outcom
infect
control
invalu
although
major
outbreak
occur
sinc
last
report
sar
case
involv
laboratori
personnel
singapor
taiwan
resid
guangdong
epidem
possibl
time
whether
sar
reappear
caus
anoth
pandem
remain
unknown
appear
merscov
anoth
highli
pathogen
zoonot
cov
continu
circul
middl
east
remind
physician
public
health
author
threat
cov
outbreak
ever
present
